NCT04572165 2024-01-02
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Novo Nordisk A/S
Unknown
Novo Nordisk A/S
University of Pecs
Ministry of Health, Saudi Arabia
Qianfoshan Hospital
University of Vienna
Southern Cross Fertility Centre
Nagaoka Red Cross Hospital
Odense University Hospital